Skip To Main Content
J. Barbaric on Muck Rack

J. Barbaric

As seen in: Color Research & Application
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with J.

Contact J., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Rifampin alone may be enough. Is it time to abandon the classic oral clindamycin ‐ rifampicin combination for hidradenitis suppurativa?

|
By J. Albrecht, J. Barbaric
| Wiley Online Library Verified
In this issue, a “Critically Appraised Topic” assesses the long‐term safety of clindamycin and rifampicin in hidradenitis suppurativa (HS). 1 It concludes that the long‐term use of these drugs is generally safe. As described in the CAT, the treatment approach with rifampicin was adapted from a case of dissecting cellulitis successfully treated with rifampicin as a monotherapy.
Open in Who Shared Issue with article?

Rifampin alone may be enough. Is it time to abandon the classic oral clindamycin ‐ rifampicin combination for hidradenitis suppurativa?

|
By J. Albrecht, J. Barbaric
| Color Research & Application Verified
The full text of this article hosted at iucr.org is unavailable due to technical difficulties. Letter to the Editor Rifampin alone may be enough. Is it time to abandon the classic oral clindamycin ‐ rifampicin combination for hidradenitis suppurativa? J.
Open in Who Shared Issue with article?

光疗祛痘:包含等级评估的缩减版科克伦系统综述 - Barbaric - 2018 - British Journal of Dermatology - Wiley Online Library

|
By J. Barbaric, R. Abbott, P. Posadzki, M. Car, L. H. Gunn, A. M. Layton, A. Majeed, J. Car
| Color Research & Application Verified
Summary??????????????,????????????????????????????????????????????,????????????????????????????????????,????????????????????????(???????)???????????????,??????????:?????(?:?????????????)??????????????????,?????????????????????????????????????????????,?????????????????????????????????????(??)??,?????????,???????????????(??)????????????????????,?????????????,????????????????(???????????)???????????????????????
Open in Who Shared Issue with article?
See all 5 articles